These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11830758)

  • 1. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
    McGaraughty S; Cowart M; Jarvis MF
    CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors.
    McGaraughty S; Cowart M; Jarvis MF; Berman RF
    Curr Top Med Chem; 2005; 5(1):43-58. PubMed ID: 15638777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonnucleoside inhibitors of adenosine kinase.
    Gomtsyan A; Lee CH
    Curr Pharm Des; 2004; 10(10):1093-103. PubMed ID: 15078144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine kinase inhibitors.
    Kowaluk EA; Bhagwat SS; Jarvis MF
    Curr Pharm Des; 1998 Oct; 4(5):403-16. PubMed ID: 10197052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor.
    Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS
    J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.
    Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS
    J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor.
    Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA
    Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of adenosine kinase inhibitors.
    Kowaluk EA; Jarvis MF
    Expert Opin Investig Drugs; 2000 Mar; 9(3):551-64. PubMed ID: 11060695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of adenosine kinase inhibition-Revisited.
    Jarvis MF
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00506. PubMed ID: 31367385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats.
    Jarvis MF; Mikusa J; Chu KL; Wismer CT; Honore P; Kowaluk EA; McGaraughty S
    Pharmacol Biochem Behav; 2002 Oct; 73(3):573-81. PubMed ID: 12151032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis.
    Boyle DL; Kowaluk EA; Jarvis MF; Lee CH; Bhagwat SS; Williams M; Firestein GS
    J Pharmacol Exp Ther; 2001 Feb; 296(2):495-500. PubMed ID: 11160636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.
    Wiesner JB; Ugarkar BG; Castellino AJ; Barankiewicz J; Dumas DP; Gruber HE; Foster AC; Erion MD
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1669-77. PubMed ID: 10336567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity.
    Zheng GZ; Mao Y; Lee CH; Pratt JK; Koenig JR; Perner RJ; Cowart MD; Gfesser GA; McGaraughty S; Chu KL; Zhu C; Yu H; Kohlhaas K; Alexander KM; Wismer CT; Mikusa J; Jarvis MF; Kowaluk EA; Stewart AO
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3041-4. PubMed ID: 12941329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice.
    Kowaluk EA; Kohlhaas KL; Bannon A; Gunther K; Lynch JJ; Jarvis MF
    Pharmacol Biochem Behav; 1999 May; 63(1):83-91. PubMed ID: 10340527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors.
    Cowart M; Lee CH; Gfesser GA; Bayburt EK; Bhagwat SS; Stewart AO; Yu H; Kohlhaas KL; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Alexander KM; Jarvis MF; Kowaluk EA
    Bioorg Med Chem Lett; 2001 Jan; 11(1):83-6. PubMed ID: 11140740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and biochemical studies on novel non-nucleoside inhibitors of the enzyme adenosine kinase.
    Park J; Vaidyanathan G; Singh B; Gupta RS
    Protein J; 2007 Apr; 26(3):203-12. PubMed ID: 17205396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
    Muchmore SW; Smith RA; Stewart AO; Cowart MD; Gomtsyan A; Matulenko MA; Yu H; Severin JM; Bhagwat SS; Lee CH; Kowaluk EA; Jarvis MF; Jakob CL
    J Med Chem; 2006 Nov; 49(23):6726-31. PubMed ID: 17154503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors.
    Lee CH; Daanen JF; Jiang M; Yu H; Kohlhaas KL; Alexander K; Jarvis MF; Kowaluk EL; Bhagwat SS
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2419-22. PubMed ID: 11549437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.